# Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)

> **NCT00996723** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 25 (actual)

## Conditions studied

- Diffuse Intrinsic Pontine Glioma

## Interventions

- **DRUG:** vandetanib and dasatinib

## Key facts

- **NCT ID:** NCT00996723
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-04
- **Final completion:** 2014-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2015-04-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00996723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00996723, "Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00996723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*